Efficacy and Safety of Mitiglinide in Korean Type 2 Diabetic Patients: Prospective Randomised Multicenter Comparative Phase III Study
Open Access
- 1 January 2007
- journal article
- Published by Korean Diabetes Association in The Journal of Korean Diabetes Association
- Vol. 31 (2), 163-174
- https://doi.org/10.4093/jkda.2007.31.2.163
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Study of nateglinide in Japan: Long-term treatment of patients with type 2 diabetesAdvances in Therapy, 2006
- Pharmacology of the Meglitinide AnalogsTreatments in Endocrinology, 2003
- Meglitinide Analogues in the Treatment of Type 2 Diabetes MellitusDrugs & Aging, 2000
- Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteriaThe Lancet, 1999
- Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.Diabetes Care, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- High Blood Glucose Concentration Is a Risk Factor for Mortality in Middle-Aged Nondiabetic Men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen StudyDiabetes Care, 1998
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusThe New England Journal of Medicine, 1993
- Plasma Insulin Concentrations in Nondiabetic and Early Diabetic Subjects: Determinations by a New Sensitive Immuno-assay TechnicDiabetes, 1960